eMedicine Specialties > Dermatology > Pediatric Diseases

Epidermal Nevus Syndrome

Author: Robert A Schwartz, MD, MPH, Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Coauthor(s): Sergiusz Jozwiak, MD, PhD, Head, Professor, Department of Child Neurology, The Children's Memorial Health Institute of Warsaw, Poland
Contributor Information and Disclosures

Updated: Jul 2, 2009

Introduction

Background

Epidermal nevi (EN) are congenital hamartomas of embryonal ectodermal origin classified on the basis of their main component; the component may be sebaceous, apocrine, eccrine, follicular, or keratinocytic. An estimated one third of individuals with epidermal nevi have involvement of other organ systems; hence, this condition is considered to be an epidermal nevus syndrome (ENS). Solomon defines epidermal nevus syndrome as a sporadic neurocutaneous linkage of congenital ectodermal defects in the skin, brain, eyes, and/or skeleton. Epidermal nevus syndrome is often termed the Solomon syndrome. Schimmelpenning first detailed epidermal nevi with neurologic anomalies; hence, the term Schimmelpenning syndrome. The term organoid nevus may be used to emphasize the admixture of epidermal cells often evident in individual lesions of epidermal nevi.

Gustav Schimmelpenning, born in 1928 in Oldenburg (Germany), served from 1971-1994 as the head of the Department of Psychiatry at the University of Kiel.1 In 1957, he described a case of sebaceous nevus involving the head, with ipsilateral ocular lesions including coloboma of the upper lid, increased density of cranial bones, epileptic seizures, and mental retardation. He called this combination of anomalies a new phacomatosis. Subsequently, others reported this phenotype as Schimmelpenning syndrome, Feuerstein-Mims syndrome, Schimmelpenning-Feuerstein-Mims syndrome, epidermal nevus syndrome, Solomon syndrome, linear sebaceous nevus (LSN) syndrome, organoid nevus phacomatosis, or Jadassohn nevus phacomatosis.

A clinical entity called epidermal nevus syndrome should be more precisely defined and distinguished by clinical, histopathologic, and genetic criteria. In this review, 4 distinct epidermal nevus syndromes, recognizable by the different types of associated epithelial nevi, are described. These include linear sebaceous nevus, linear nevus comedonicus (NC), linear epidermal nevus (LEN), and inflammatory linear verrucous epidermal nevus (ILVEN). Each type may be regarded as part of a syndrome with systemic associations.

Linear epidermal nevus syndrome is a congenital neurocutaneous disorder characterized by linear epidermal nevus with significant involvement of the nervous, ophthalmologic, and/or skeletal systems.2 Clinical manifestations include mental retardation, seizures, and movement disorders that are caused by a wide range of neuropathologic lesions. Intracranial and/or intraspinal lipomas may occur.

Linear sebaceous nevus, also known as organoid nevus syndrome, often has the term linear deleted because almost all syndromic sebaceous nevi are linear. It has also been called Schimmelpenning-Feuerstein-Mims syndrome and Jadassohn nevus phakomatosis. Schimmelpenning syndrome, as noted above, links a sebaceous nevus with cerebral anomalies, coloboma, and lipodermoid of the conjunctiva.

Linear nevus comedonicus is also known as comedone nevus, nevus follicularis keratosus, nevus acneiformis unilateralis, and nevus zoniform. Cataracts may be a prominent feature of nevus comedonicus syndrome.

Inflammatory linear verrucous epidermal nevus is a linear, persistent, pruritic plaque, usually first noted on a limb in early childhood. Originally described by Unna in 1896, a few patients were reported prior to 1971 when Altman and Mehregan3 delineated inflammatory linear verrucous epidermal nevus as a distinct entity in 25 patients. They coined the name inflammatory linear verrucous epidermal nevus, labeling it a clinical and histopathologic type of linear verrucous nevus that is often inflammatory or psoriasiform. Inflammatory linear verrucous epidermal nevus accounts for approximately 5% of patients with epidermal nevi and has been described in a mother and daughter.

Six different syndromes with epidermal nevi as part of them have been delineated. These include (1) Proteus, (2) congenital hemidysplasia with ichthyosiform nevus and limb defect, (3) phakomatosis pigmentokeratotica, (4) sebaceous nevus, (5) Becker nevus, and (6) nevus comedonicus4 syndromes.

The spectrum has recently been expanded with the description of linear Cowden nevus as a new distinct epidermal nevus.5 This nonorganoid epidermal nevus is probably due to loss of heterozygosity, occurring at an early developmental stage in an embryo with a germline PTEN mutation, giving rise to Cowden disease.

Pathophysiology

Epidermal nevi arise from pluripotential germinative cells of the basal layer of the embryonic epidermis.

Inflammatory linear verrucous epidermal nevus is distinct from psoriasis; however, they may share some common pathogenic pathways. These pathways are probably mediated by interleukin 1, interleukin 6, tumor necrosis factor-alpha, and intercellular adhesion molecule-1.

Epidermal nevus syndrome–associated skeletal disease focal bone defects may manifest as fibrous dysplasia, even without the typical radiographic or histopathologic findings of fibrous dysplasia.6 A patient had elevated circulating fibroblast growth factor 23 (FGF-23) levels with no activating mutations. This focal skeletal disease may be a source of FGF-23 in persons with epidermal nevus syndrome and thus may be a clue to its pathogenesis.

A bilateral, systematized epidermal nevus syndrome patient was described with cerebral involvement caused by a mosaic FGFR3 mutation, possibly representing a distinct entity within the group of epidermal nevus syndromes.7

Frequency

International

The syndromes are uncommon. In a review by Rogers and associates8 of 131 patients with epidermal nevi and epidermal nevus syndrome, one third of the patients had the nevus sebaceous type, 60% had the noninflammatory type, 6% had inflammatory linear verrucous epidermal nevus, and only 2 had nevus comedonicus.

Mortality/Morbidity

Mortality and morbidity are related to the associated systemic anomalies.

Sex

  • Linear sebaceous nevus syndrome and nevus comedonicus syndrome have a female-to-male ratio of 1:1. This ratio may also be true of linear epidermal nevus.
  • Inflammatory linear verrucous epidermal nevus has a female predominance, with a female-to-male ratio of 4:1.

Age

The age at diagnosis ranges from birth to age 40 years.

Clinical

History

  • Epidermal nevi are patches, plaques, or nodules that may be bilateral or distributed on most of the body. Usually, no symptoms of the nevi are present, with the exception of inflammatory linear verrucous epidermal nevus.
  • Inflammatory linear verrucous epidermal nevus is a linear, persistent, pruritic plaque, usually first noted on a limb in early childhood. The clinical history may reflect symptoms associated with underlying anomalies. Inflammatory linear verrucous epidermal nevus, unlike the other types of epidermal nevi, demonstrates erythema and sometimes pruritus.

Physical

Linear nevus comedonicus

Nevus comedonicus is evident clinically as confluent clusters of dilated follicular orifices plugged with keratin, giving the appearance of aggregated open comedones. These clusters are often arranged in a linear or zosteriform pattern, occasionally paralleling the lines of Voigt or the lines of Blaschko.

Although usually unilateral, bilateral occurrences have been noted. As with other epidermal nevi, the most common sites are the face, the trunk, and proximal extremities.

Nevus comedonicus may be associated with a number of other cutaneous and internal defects, such as skeletal anomalies (eg, scoliosis, fused vertebrae or hemivertebrae, spina bifida occulta, absent fifth finger), central nervous system defects (eg, seizures, changes noted on EEG, transverse myelitis), and ocular alterations (eg, cataracts).

Inflammatory linear verrucous epidermal nevus

Inflammatory linear verrucous epidermal nevus is a linear, persistent, pruritic plaque, usually first noted on a limb in early childhood. Inflammatory linear verrucous epidermal nevus is characterized by tiny, discrete, erythematous, slightly warty papules, which tend to coalesce in a linear formation.

Altman and Mehregan3 delineated 6 characteristic features: early age at onset, predominance in females (with a female-to-male ratio of 4:1), frequent involvement of the left leg, pruritus, marked refractoriness to therapy, and a distinctive psoriasiform and inflammatory histologic appearance.

The lesions may be observed at birth, but most appear during infancy and childhood. In the study by Altman and Mehregan,3 one half of patients were noted to have lesions by age 6 months with three quarters of the 25 patients developing lesions by age 5 years. Several patients were noted to develop lesions at an older age (eg, 1 patient developed a lesion at 49 y). The left side of the body, particularly on the left lower extremity, was more often involved.

Inflammatory linear verrucous epidermal nevus may occur with musculoskeletal abnormalities in a few children, prompting the classification of inflammatory linear verrucous epidermal nevus as part of epidermal nevus syndrome. One infant had inflammatory linear verrucous epidermal nevus with congenital dislocation of the ipsilateral hip and Fallot tetralogy of the heart. Another infant had congenital inflammatory linear verrucous epidermal nevus with congenital bony anomalies of the ipsilateral extremities. Nevus depigmentosus and inflammatory linear verrucous epidermal nevus may occur together, as may inflammatory linear verrucous epidermal nevus and melanodontia.

Linear sebaceous nevus (Jadassohn nevus phacomatosis)

 

Characteristic epidermal nevus in the axillary fo...

Characteristic epidermal nevus in the axillary fossa of a child with Jadassohn nevus phakomatosis (same patient as in Media Files 2-3).

Characteristic epidermal nevus in the axillary fo...

Characteristic epidermal nevus in the axillary fossa of a child with Jadassohn nevus phakomatosis (same patient as in Media Files 2-3).


An extensive plaque is observed over most of the ...

An extensive plaque is observed over most of the left scapula, neck area, and lumbosacral location (same patient as in Media Files 1 and 3).

An extensive plaque is observed over most of the ...

An extensive plaque is observed over most of the left scapula, neck area, and lumbosacral location (same patient as in Media Files 1 and 3).


Plaque is evident in the region of the left groin...

Plaque is evident in the region of the left groin, and it has a unilateral distribution (same patient as in Media Files 1-2).

Plaque is evident in the region of the left groin...

Plaque is evident in the region of the left groin, and it has a unilateral distribution (same patient as in Media Files 1-2).


In 84% of patients with linear sebaceous nevus, skin lesions are on the face, and in approximately 50%, lesions are on the scalp, the neck, and the forehead. In most patients, the lesions appear on 1 side of the body (nevus unius lateralis). Lesions on the scalp are devoid of hair.

Seizures are reported in 75% of patients with linear sebaceous nevus, mostly appearing in the first 6 months of life. The morphology of the seizures varies from infantile spasms or focal motor seizures to generalized tonic or tonic-clonic seizures. In some children, seizures are drug resistant and may result in progressive mental retardation, which is noted in approximately 70% of patients with Jadassohn nevus phacomatosis. Such regression of mental capacity is not observed in older children or adolescents.

Approximately 50% of patients demonstrate different neurologic deficits, including cranial nerve paresis (cranial nerves VI and VII), hemiparesis, or cortical blindness.

Linear sebaceous nevus syndrome is composed of multiple, well-demarcated linear, hairless plaques with evidence of neurologic or skeletal alterations, such as epilepsy or mental retardation. Skin lesions in linear sebaceous nevus syndrome are less obvious in infancy, and they are a smooth yellow-orange plaque. The nevus distribution pattern in this Schimmelpenning syndrome usually follows the lines of Blaschko. With age, these lesions become more visible, darker, verrucous, and hyperkeratotic. The last stage of development occurs in late adolescence or early adult life. The verrucous nature of the lesions is further emphasized with cutaneous benign or malignant neoplasms noted in as many as 20-30% of patients. Syringocystadenoma papilliferum is the most likely benign neoplasm, whereas basal cell carcinoma, squamous cell carcinoma, and keratoacanthoma are the most common in the malignant category.9

Extensive unilateral linear epidermal nevi in a 1...

Extensive unilateral linear epidermal nevi in a 14-year-old girl with Jadassohn nevus phakomatosis. The plaques are elevated; some have verrucous characteristics.

Extensive unilateral linear epidermal nevi in a 1...

Extensive unilateral linear epidermal nevi in a 14-year-old girl with Jadassohn nevus phakomatosis. The plaques are elevated; some have verrucous characteristics.


An 8-year-old girl with Jadassohn nevus syndrome....

An 8-year-old girl with Jadassohn nevus syndrome. Note typical plaques in the midline and on the arm and the neck. The plaques are darker and more verrucous on the arm and the neck than on the midline.

An 8-year-old girl with Jadassohn nevus syndrome....

An 8-year-old girl with Jadassohn nevus syndrome. Note typical plaques in the midline and on the arm and the neck. The plaques are darker and more verrucous on the arm and the neck than on the midline.


Linear epidermal nevus

Linear epidermal nevus may be bilateral or distributed on most of the body. The lesions appear as asymptomatic patches or plaques, with the head and the neck, as well as the trunk, being the most common sites.

The lesions may have a somewhat verrucous appearance. They lack erythema, and they are not pruritic.

An epidermal nevus may be associated with oral involvement and cleft palate.10

Causes

The basis of the cause may be the activation of an autosomal dominant lethal mutation that survives by mosaicism. These cells might survive only by being adjacent to normal ones11 Inflammatory linear verrucous epidermal nevus has been described in a mother and daughter.

More on Epidermal Nevus Syndrome

Overview: Epidermal Nevus Syndrome
Differential Diagnoses & Workup: Epidermal Nevus Syndrome
Treatment & Medication: Epidermal Nevus Syndrome
Follow-up: Epidermal Nevus Syndrome
Multimedia: Epidermal Nevus Syndrome
References

References

  1. Happle R. Gustav Schimmelpenning and the syndrome bearing his name. Dermatology. 2004;209(2):84-7. [Medline].

  2. Mall V, Heinen F, Uhl M, Wellens E, Korinthenberg R. CNS lipoma in patients with epidermal nevus syndrome. Neuropediatrics. Aug 2000;31(4):175-9. [Medline].

  3. Altman J, Mehregan AH. Inflammatory linear verrucose epidermal nevus. Arch Dermatol. Oct 1971;104(4):385-9. [Medline].

  4. Vidaurri-de la Cruz H, Tamayo-Sanchez L, Duran-McKinster C, de la Luz Orozco-Covarrubias M, Ruiz-Maldonado R. Epidermal nevus syndromes: clinical findings in 35 patients. Pediatr Dermatol. Jul-Aug 2004;21(4):432-9. [Medline].

  5. Happle R. Linear Cowden nevus: a new distinct epidermal nevus. Eur J Dermatol. Mar-Apr 2007;17(2):133-6. [Medline].

  6. Heike CL, Cunningham ML, Steiner RD, et al. Skeletal changes in epidermal nevus syndrome: does focal bone disease harbor clues concerning pathogenesis?. Am J Med Genet A. Dec 1 2005;139A(2):67-77. [Medline].

  7. Garcia-Vargas A, Hafner C, Perez-Rodriguez AG, et al. An epidermal nevus syndrome with cerebral involvement caused by a mosaic FGFR3 mutation. Am J Med Genet A. Sep 1 2008;146A(17):2275-9. [Medline].

  8. Rogers M, McCrossin I, Commens C. Epidermal nevi and the epidermal nevus syndrome. A review of 131 cases. J Am Acad Dermatol. Mar 1989;20(3):476-88. [Medline].

  9. Ball EA, Hussain M, Moss AL. Squamous cell carcinoma and basal cell carcinoma arising in a naevus sebaceous of Jadassohn: case report and literature review. Clin Exp Dermatol. May 2005;30(3):259-60. [Medline].

  10. Menni S, Boccardi D, Gualandri L. Keratinocytic epidermal nevus with oral involvement and cleft palate. G Ital Dermatol Venereol. Oct 2008;143(5):347-9. [Medline].

  11. Happle R. Epidermal nevus syndromes. Semin Dermatol. Jun 1995;14(2):111-21. [Medline].

  12. Mahto M, Ashworth J, Vickers DM. A case of linear epidermal naevus presenting as genital warts--a cautionary tale. Int J STD AIDS. Mar 2005;16(3):267-9. [Medline].

  13. Wiedemeyer K, Hartschuh W. Trichoblastomas with Merkel cell proliferation in nevi sebacei in Schimmelpenning-Feuerstein-Mims syndrome - Histological differentiation between trichoblastomas and basal cell carcinomas. J Dtsch Dermatol Ges. Feb 2 2009;[Medline].

  14. Jaqueti G, Requena L, Sanchez Yus E. Trichoblastoma is the most common neoplasm developed in nevus sebaceus of Jadassohn: a clinicopathologic study of a series of 155 cases. Am J Dermatopathol. Apr 2000;22(2):108-18. [Medline].

  15. Micali G, Nasca MR, Musumeci ML. Effect of topical calcipotriol on inflammatory linear verrucous epidermal nevus. Pediatr Dermatol. Dec 1995;12(4):386-7. [Medline].

  16. Zvulunov A, Grunwald MH, Halvy S. Topical calcipotriol for treatment of inflammatory linear verrucous epidermal nevus. Arch Dermatol. May 1997;133(5):567-8. [Medline].

  17. Davison SP, Khachemoune A, Yu D, Kauffman LC. Nevus sebaceus of Jadassohn revisited with reconstruction options. Int J Dermatol. Feb 2005;44(2):145-50. [Medline].

  18. Winston KR, Kang J, Laoprasert P, Kleinschmidt-DeMasters BK. Hemispherectomy in a premature neonate with linear sebaceous nevus syndrome. Pediatr Neurosurg. 2008;44(2):159-64. [Medline].

  19. Adrian RM, Baden HP. Analysis of epidermal fibrous proteins in inflammatory linear verrucous epidermal nevus. Arch Dermatol. Oct 1980;116(10):1179-80. [Medline].

  20. al-Fouzan AS, Hassab-el-Naby HM, Nanda A. Congenital linear psoriasis: a case report. Pediatr Dermatol. Dec 1990;7(4):303-6. [Medline].

  21. Allison MA, Dunn CL, Pedersen RC. What syndrome is this? Epidermal nevus syndrome: a neurologic variant with hemimegalencephaly, facial hemihypertrophy and gyral malformation. Pediatr Dermatol. Jan-Feb 1998;15(1):59-61. [Medline].

  22. Bazopoulou-Kyrkanidou E, Alexandridis C, Tosios KI, Sotiriadou S, Angelopoulos AP. Epidermal nevus syndrome with development of a mandibular ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Jul 2000;90(1):64-70. [Medline].

  23. Bernhard JD, Owen WR, Steinman HK, Kaplan LA, Menkes AB, Baden HP. Inflammatory linear verrucous epidermal nevus. Epidermal protein analysis in four patients. Arch Dermatol. Feb 1984;120(2):214-5. [Medline].

  24. Bittar M, Happle R. CHILD syndrome avant la lettre. J Am Acad Dermatol. Feb 2004;50(2 Suppl):S34-7. [Medline].

  25. Canyigit M, Oguz KK. Epidermal nevus syndrome with internal carotid artery occlusion and intracranial and orbital lipomas. AJNR Am J Neuroradiol. Aug 2006;27(7):1559-61. [Medline].

  26. Caux F, Plauchu H, Chibon F, et al. Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity. Eur J Hum Genet. Jul 2007;15(7):767-73. [Medline].

  27. Crovato F, De Marchi R, Nazzari G, Desirello G, Giunchedi M. [Schimmelpenning-Feuerstein-Mims syndrome, a variant of the epidermal nevus syndrome]. G Ital Dermatol Venereol. Jul-Aug 1983;118(4):211-4. [Medline].

  28. Domanska-Pakiela D, Jozwiak S. Modern opinions on etiopathogenesis, diagnosis and treatment of Jadassohn nevus syndrome. Ped Polska. 1998;73:1297-1301.

  29. Farajzadeh S, Zahedi MJ, Moghaddam SD. A new gastrointestinal finding in Proteus syndrome: report of a case of multiple colonic hemangiomas. Int J Dermatol. Feb 2006;45(2):135-8. [Medline].

  30. Fink-Puches R, Soyer HP, Pierer G, Kerl H, Happle R. Systematized inflammatory epidermal nevus with symmetrical involvement: an unusual case of CHILD syndrome?. J Am Acad Dermatol. May 1997;36(5 Pt 2):823-6. [Medline].

  31. Fitzpatrick TB, Mihm MC. Multiple melanocytoma. Arch Dermatol. Jul 1970;102(1):126. [Medline].

  32. Gobello T, Mazzanti C, Zambruno G, Chinni LM, Happle R. New type of epidermal nevus syndrome. Dermatology. 2000;201(1):51-3. [Medline].

  33. Golitz LE, Weston WL. Inflammatory linear verrucous epidermal nevus. Association with epidermal nevus syndrome. Arch Dermatol. Oct 1979;115(10):1208-9. [Medline].

  34. Happle R. How many epidermal nevus syndromes exist? A clinicogenetic classification. J Am Acad Dermatol. Sep 1991;25(3):550-6. [Medline].

  35. Hodge JA, Ray MC, Flynn KJ. The epidermal nevus syndrome. Int J Dermatol. Feb 1991;30(2):91-8. [Medline].

  36. Hsu S, Nikko A. Unilateral atrophic skin lesion with features of atrophoderma vermiculatum: a variant of the epidermal nevus syndrome?. J Am Acad Dermatol. Aug 2000;43(2 Pt 1):310-2. [Medline].

  37. Ivker R, Resnick SD, Skidmore RA. Hypophosphatemic vitamin D-resistant rickets, precocious puberty, and the epidermal nevus syndrome. Arch Dermatol. Dec 1997;133(12):1557-61. [Medline].

  38. Jozwiak S, Domanska-Pakiela D, Potakiewicz W. Clinical observations of Jadassohn nevus syndrome in 7 children. Ped Polska. 1998;73:1273-1278.

  39. Jurecka W, Neumann RA, Knobler RM. Porokeratoses: immunohistochemical, light and electron microscopic evaluation. J Am Acad Dermatol. Jan 1991;24(1):96-101. [Medline].

  40. Kawaguchi H, Takeuchi M, Ono H, Nakajima H. Adult onset of inflammatory linear verrucous epidermal nevus. J Dermatol. Sep 1999;26(9):599-602. [Medline].

  41. Kishida ES, Muniz Silva MA, da Costa Pereira F, Sanches JA Jr, Sotto MN. Epidermal nevus syndrome associated with adnexal tumors, spitz nevus, and hypophosphatemic vitamin D-resistant rickets. Pediatr Dermatol. Jan-Feb 2005;22(1):48-54. [Medline].

  42. Lefkowitz A, Schwartz RA, Lambert WC. Nevus comedonicus. Dermatology. 1999;199(3):204-7. [Medline].

  43. Menascu S, Donner EJ. Linear nevus sebaceous syndrome: case reports and review of the literature. Pediatr Neurol. Mar 2008;38(3):207-10. [Medline].

  44. Micali G, Nasca MR, De Pasquale R. Linear acantholytic dyskeratotic epidermal nevus of the sole. Pediatr Dermatol. Mar-Apr 1999;16(2):166-8. [Medline].

  45. Mikulska D, Nowak A. A case of Darier-like epidermal nevus. Postepy Dermatol (Poznan). 2000;17:347-350.

  46. Miteva LG, Dourmishev AL, Schwartz RA. Inflammatory linear verrucous epidermal nevus. Cutis. Nov 2001;68(5):327-30. [Medline].

  47. Ogunbiyi AO, Ogunbiyi JO. Nevus depigmentosus and inflammatory linear epidermal nevus--an unusual combination with a note on histology. Int J Dermatol. Aug 1998;37(8):600-2. [Medline].

  48. Pandhi D, Reddy BS. A rare association of epidermal nevus syndrome and ainhum-like digital constrictions. Pediatr Dermatol. Jul-Aug 2002;19(4):349-52. [Medline].

  49. Parano E, Rizzo R, Micali G, et al. Woolly hair nevus and linearepidermal nevus: a clinical association. Giornale Int Dermatol Pediatr. 1993;5:73-6.

  50. Pavone L, Curatolo P, Rizzo R, et al. Epidermal nevus syndrome: a neurologic variant with hemimegalencephaly, gyral malformation, mental retardation, seizures, and facial hemihypertrophy. Neurology. Feb 1991;41(2 (Pt 1)):266-71. [Medline].

  51. Perez Chavarria EL, Castellanos E, Linares L. Sindrome del nevo sebaceo. Med Cutanea. 1996;24:73-5.

  52. Piper HF, Bastian GO. [Epidermal nevus syndrome (Schimmelpenning-Feuerstein-Mims syndrome) and early childhood cataract development]. Klin Monatsbl Augenheilkd. Apr 1983;182(4):318-21. [Medline].

  53. Prayson RA, Kotagal P, Wyllie E, Bingaman W. Linear epidermal nevus and nevus sebaceus syndromes: a clinicopathologic study of 3 patients. Arch Pathol Lab Med. Apr 1999;123(4):301-5. [Medline].

  54. Rahbari H, Cordero AA, Mehregan AH. Linear porokeratosis. A distinctive clinical variant of porokeratosis of Mibelli. Arch Dermatol. Apr 1974;109(4):526-8. [Medline].

  55. Rogers M. Epidermal nevi and the epidermal nevus syndromes: a review of 233 cases. Pediatr Dermatol. Dec 1992;9(4):342-4. [Medline].

  56. Saedi T, Cetas J, Chang R, Krol A, Selden NR. Newborn with sebaceous nevus of jadassohn presenting as exophytic scalp lesion. Pediatr Neurosurg. 2008;44(2):144-7. [Medline].

  57. Sasaki M, Matsuda H, Arai Y, Hashimoto T. Startle-induced epilepsy in a patient with epidermal nevus syndrome. Pediatr Neurol. Apr 1998;18(4):346-9. [Medline].

  58. Schepis C, Greco D, Siragusa M, Batolo D, Romano C. Rubinstein-Taybi syndrome with epidermal nevus: a case report. Pediatr Dermatol. Jan-Feb 2001;18(1):34-7. [Medline].

  59. Solomon LM. Epidermal nevus syndrome. Mod Probl Paediatr. 1975;17:27-30. [Medline].

  60. Stein KM, Shmunes E, Thew M. Neurofibromatosis presenting as the epidermal nevus syndrome. Arch Dermatol. Feb 1972;105(2):229-32. [Medline].

  61. Surve TY, Muranjan MN, Deshmukh CT, Warke CS, Bharucha BA. Inflammatory linear verrucous epidermal nevus syndrome with bilateral vertebral artery occlusion. Indian Pediatr. Aug 1999;36(8):820-3. [Medline].

  62. Thivolet J, Goujon C. Linear psoriasis and systematized epidermolytic nevus. Arch Dermatol. Apr 1982;118(4):285-6. [Medline].

  63. Waltz KM, Helm KF, Billingsley EM. The spectrum of epidermal nevi: a case of verrucous epidermal nevus contiguous with nevus sebaceus. Pediatr Dermatol. May-Jun 1999;16(3):211-3. [Medline].

  64. Welch ML, Smith KJ, Skelton HG, et al. Immunohistochemical features in inflammatory linear verrucous epidermal nevi suggest a distinctive pattern of clonal dysregulation of growth. Military Medical Consortium for the Advancement of Retroviral Research. J Am Acad Dermatol. Aug 1993;29(2 Pt 1):242-8. [Medline].

  65. Yu TW, Tsau YK, Young C, Chiu HC, Shen YZ. Epidermal nevus syndrome with hypermelanosis and chronic hyponatremia. Pediatr Neurol. Feb 2000;22(2):151-4. [Medline].

  66. Zaremba J. Jadassohn's naevus phakomatosis: 2. A study based on a review of thirty-seven cases. J Ment Defic Res. Jun 1978;22(2):103-23. [Medline].

  67. Zgrzyblowski A, Ryc K, Paradecki W. [Inflammatory linear verrucous epidermal naevus (Ilven)]. Przegl Dermatol. Jan-Feb 1988;75(1):46-9. [Medline].

Further Reading

Keywords

epidermal nevus syndrome, epidermal nevus, epidermal nevi, EN, Solomon syndrome, linear sebaceous epidermal nevus syndrome, LSN, inflammatory linear verrucous epidermal nevus syndrome, ILVEN, Schimmelpenning syndrome, Schimmelpenning-Feuerstein-Mims syndrome, nevus comedonicus syndrome, NC, proteus syndrome, congential hemidysplasia with ichthyosiform nevus and limb defects, CHILD syndrome, Jadassohn nevus syndrome, nevus unius lateralis syndrome, ENS, linear epidermal nevus, LEN

Contributor Information and Disclosures

Author

Robert A Schwartz, MD, MPH, Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi
Disclosure: Nothing to disclose.

Coauthor(s)

Sergiusz Jozwiak, MD, PhD, Head, Professor, Department of Child Neurology, The Children's Memorial Health Institute of Warsaw, Poland
Sergiusz Jozwiak, MD, PhD is a member of the following medical societies: Sigma Xi
Disclosure: Nothing to disclose.

Medical Editor

Mark A Crowe, MD, Assistant Clinical Instructor, Department of Medicine, Division of Dermatology, University of Washington School of Medicine
Mark A Crowe, MD is a member of the following medical societies: American Academy of Dermatology and North American Clinical Dermatologic Society
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Managing Editor

Van Perry, MD, Assistant Professor, Department of Medicine, Division of Dermatology, University of Texas Health Science Center
Van Perry, MD is a member of the following medical societies: American Academy of Dermatology and American Society for Laser Medicine and Surgery
Disclosure: Nothing to disclose.

CME Editor

Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital
Glen H Crawford, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Phi Beta Kappa, and Society of USAF Flight Surgeons
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
RELATED MEDSCAPE ARTICLES
Articles
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.